Chemoinformaics analysis of 4-HYDROXY-3,5-DIMETHOXYBENZOIC ACID
| Molecular Weight | 396.348 | nRot | 6 |
| Heavy Atom Molecular Weight | 376.188 | nRig | 7 |
| Exact Molecular Weight | 396.106 | nRing | 2 |
| Solubility: LogS | -1.975 | nHRing | 0 |
| Solubility: LogP | 1.212 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 51.4159 |
| nHD | 4 | BPOL | 28.7441 |
| QED | 0.76 |
| Synth | 1.726 |
| Natural Product Likeliness | 0.544 |
| NR-PPAR-gamma | 0.235 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.003 |
| HIA | 0.028 |
| CACO-2 | -5.142 |
| MDCK | 0.0000109 |
| BBB | 0.457 |
| PPB | 0.508902 |
| VDSS | 0.459 |
| FU | 0.385661 |
| CYP1A2-inh | 0.032 |
| CYP1A2-sub | 0.911 |
| CYP2c19-inh | 0.025 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.131 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.071 |
| CL | 7.208 |
| T12 | 0.946 |
| hERG | 0.034 |
| Ames | 0.009 |
| ROA | 0.011 |
| SkinSen | 0.129 |
| Carcinogencity | 0.034 |
| EI | 0.977 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.021 |
| Antiviral | Yes |
| Prediction | 0.648514 |